Related Experiment Video
Updated: Mar 6, 2026

Differentiation of Atrial Cardiomyocytes from Pluripotent Stem Cells Using the BMP Antagonist Grem2
Published on: March 10, 2016
mTORC1 and mTORC2 play different roles in regulating cardiomyocyte differentiation from embryonic stem cells
Bei Zheng1, Jiadan Wang, Leilei Tang
1Institute of Pharmacology and Toxicology, Zhejiang University, Hangzhou, China.
Abstract:
Mammalian target of rapamycin (mTOR) is a serine/threonine kinase and functions through two distinct complexes, mTOR complex 1 (mTORC1) and complex 2 (mTORC2), with their key components Raptor and Rictor, to play crucial roles in cellular survival and growth. However, the roles of mTORC1 and mTORC2 in regulating cardiomyocyte differentiation from mouse embryonic stem (mES) cells are not clear. In this study, we performed Raptor or Rictor knockdown experiments to investigate the roles of mTORC1 and mTORC2 in cardiomyocyte differentiation. Ablation of Raptor markedly increased the number of cardiomyocytes derived from mES cells with well-organized myofilaments. Expression levels of brachyury (mesoderm protein), Nkx2.5 (cardiac progenitor cell protein), and α-Actinin (cardiomyocyte marker) were increased in Raptor knockdown cells. In contrast, loss of Rictor prevented cardiomyocyte differentiation. The dual ablation of Raptor and Rictor also decreased the number of cardiomyocytes. The two complexes exerted a regulatory mechanism in such a manner that knockdown of Raptor/mTORC1 resulted in a decreased phosphorylation of Rictor (Thr1135), which subsequently activated Rictor/mTORC2 in the differentiation of mES cells into cardiomyocytes. In conclusion, mTORC1 and mTORC2 played different roles in cardiomyocyte differentiation from mES cells in vitro. The activation of Rictor/mTORC2 was critical for facilitating cardiomyocyte differentiation from mES cells. Thus, this complex may be a promising target for regulating myocardial differentiation from embryonic stem cells or induced pluripotent stem cells.
Insights
Mammalian target of rapamycin complex 2 (mTORC2) activation is critical for cardiomyocyte differentiation from mouse embryonic stem cells. mTORC1 inhibition enhances this process by upregulating mTORC2 signaling.
Area of Science:
- Cell Biology
- Developmental Biology
- Stem Cell Research
Background:
- Mammalian target of rapamycin (mTOR) signaling pathways, specifically mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2), are vital for cellular survival and growth.
- The precise roles of mTORC1 and mTORC2 in regulating cardiomyocyte differentiation from mouse embryonic stem cells (mESCs) remain largely undefined.
Purpose of the Study:
- To elucidate the distinct functions of mTORC1 and mTORC2 in directing cardiomyocyte differentiation from mESCs.
- To investigate the interplay between mTORC1 and mTORC2 during this differentiation process.
Main Methods:
- Knockdown experiments targeting Raptor (mTORC1 component) and Rictor (mTORC2 component) in mESCs.
- Quantitative analysis of cardiomyocyte differentiation markers and myofilament organization.
- Assessment of protein phosphorylation levels, specifically Rictor phosphorylation at Thr1135.
Main Results:
- Raptor ablation significantly enhanced cardiomyocyte differentiation, increasing the number of cells with organized myofilaments and upregulating cardiac markers (brachyury, Nkx2.5, α-Actinin).
- Rictor loss impaired cardiomyocyte differentiation, and dual ablation of Raptor and Rictor reduced cardiomyocyte numbers.
- Knockdown of Raptor/mTORC1 led to decreased Rictor phosphorylation, consequently activating Rictor/mTORC2 signaling and promoting mESC differentiation into cardiomyocytes.
Conclusions:
- mTORC1 and mTORC2 exhibit opposing roles in mESC-derived cardiomyocyte differentiation.
- Activation of Rictor/mTORC2 is essential for facilitating cardiomyocyte differentiation.
- Targeting mTORC2 presents a potential strategy for regulating myocardial differentiation from stem cells.
More Related Videos
09:29Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts
Published on: March 22, 2017
13:13High Efficiency Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes and Characterization by Flow Cytometry
Published on: September 23, 2014
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Master Transcription Regulators
PI3K/mTOR/AKT Signaling Pathway